Serum phosphate and outcome at oneyear after deceased donor renal transplantation

Clinical Transplantation

Volumn 25, Issue 2, 2011, Pages

  Stevens, K K ^a,b   Morgan, I R ^c   Patel, R K ^a,b   Geddes, C C ^b   Mark, P B ^a,b   Jardine, A G ^a,b   Delles, C ^a,b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b WESTERN INFIRMARY   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Deceased donor; Mortality; Outcome; Renal transplant; Risk factor; Serum phosphate

Indexed keywords

PHOSPHATE;

ADULT; ARTICLE; CADAVER KIDNEY; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PHOSPHATE BLOOD LEVEL; PREDICTOR VARIABLE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SMOKING; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; VASCULAR DISEASE;

CADAVER; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PHOSPHATES; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; TISSUE DONORS; TREATMENT OUTCOME;

EID: 79953313611     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2011.01400.x     Document Type: Article

References (16)

1. Glassock RJ, Winearls C. An epidemic of chronic kidney disease: fact or fiction? Nephrol Dial Transplant 2008: 23: 1117.
2. Kundhal K, Lok CE. Clinical epidemiology of cardiovascular disease in chronic kidney disease. Nephron Clin Pract 2005: 101: c47.
3. Fung F, Sherrard DJ, Gillen DL et al. Increased risk for cardiovascular mortality among malnourished end-stage renal disease patients. Am J Kidney Dis 2002: 40: 307.
4. Kestenbaum B, Sampson JN, Rudser KD et al. Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol 2005: 16: 520.
5. Wolfe RA, Ashby VB, Milford EL et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999: 341: 1725.
6. Schnuelle P, Lorenz D, Trede M, Van Der Woude FJ. Impact of renal cadaveric transplantation on survival in end-stage renal failure: evidence for reduced mortality risk compared with hemodialysis during long-term follow-up. J Am Soc Nephrol 1998: 9: 2135.
7. Kasiske BL. Risk factors for accelerated atherosclerosis in renal transplant recipients. Am J Med 1988: 84: 985.
8. Kopple JD, Zhu X, Lew NL, Lowrie EG. Body weight-for-height relationships predict mortality in maintenance hemodialysis patients. Kidney Int 1999: 56: 1136.
9. Zager PG, Nikolic J, Brown RH et al. "U" curve association of blood pressure and mortality in hemodialysis patients. Medical Directors of Dialysis Clinic, Inc. Kidney Int 1998: 54: 561.
10. Achinger SG, Ayus JC. Left ventricular hypertrophy: is hyperphosphatemia among dialysis patients a risk factor? J Am Soc Nephrol 2006: 17(12 Suppl 3): S255.
11. Giachelli CM. The emerging role of phosphate in vascular calcification. Kidney Int 2009: 75: 890.
12. Giachelli CM, Speer MY, Li X, Rajachar RM, Yang H. Regulation of vascular calcification: roles of phosphate and osteopontin. Circ Res 2005: 96: 717.
13. Shuto E, Taketani Y, Tanaka R et al. Dietary phosphorus acutely impairs endothelial function. J Am Soc Nephrol 2009: 20: 1504.
14. Foley RN, Collins AJ, Herzog CA, Ishani A, Kalra PA. Serum phosphorus levels associate with coronary atherosclerosis in young adults. J Am Soc Nephrol 2009: 20: 397.
15. Connolly GM, Cunningham R, McNamee PT, Young IS, Maxwell AP. Elevated serum phosphate predicts mortality in renal transplant recipients. Transplantation 2009: 87: 1040.
16. Patel RK, Mark PB, Johnston N et al. Prognostic value of cardiovascular screening in potential renal transplant recipients: a single-center prospective observational study. Am J Transplant 2008: 8: 1673.